Plumpy'nut

Plumpy'nut is a branded ready-to-use therapeutic food (RUTF) developed for the treatment of severe acute malnutrition. It is a dense peanut-based paste supplied in individual tear-open sachets and is manufactured by Nutriset, a French nutrition company. Unlike traditional therapeutic feeding based on milk formulas, the product is designed to be administered without added water, cooking, refrigeration, or extensive preparation. This makes it suitable for community-based treatment programs in famine zones, refugee settings, and other locations where hospitals, therapeutic feeding centers, clean water, electricity, and cold-chain infrastructure may be limited. The product was developed in 1996 by French pediatric nutritionist André Briend and food-processing engineer Michel Lescanne. The concept was influenced by the convenience and acceptability of chocolate-hazelnut spreads such as Nutella, but Plumpy'nut uses a different nutritional formulation. Its paste combines peanuts with sugar, vegetable oil, skimmed milk powder, vitamins, and minerals. The formulation supplies energy and a broad range of macronutrients and micronutrients intended to support rapid nutritional rehabilitation in children with severe acute malnutrition. A standard sachet weighs approximately 92 grams, and the product is commonly described in scientific and humanitarian literature as an RUTF. A central feature of Plumpy'nut is that it can be dispensed directly from the packet and eaten by a child at home or in a community setting, generally under a treatment protocol established by health services. This helped support the wider adoption of community-based management of severe acute malnutrition. Historically, many severely malnourished children required admission to a therapeutic feeding facility and treatment with therapeutic milk. Plumpy'nut and comparable RUTF products reduced the need for hospitalization for suitable cases by allowing treatment to move closer to patients and their families. The product is not intended as ordinary food, a general dietary supplement, or a routine nutrition product for people without severe acute malnutrition. Plumpy'nut became closely associated with international famine relief and child-survival operations. Its shelf stability, portability, ease of use, and lack of refrigeration requirements made it valuable to agencies procuring large quantities for emergency programs. UNICEF and other humanitarian organizations used RUTF approaches in responses to severe malnutrition, including the Niger emergency of 2007. The product's use depends on clinical screening and program protocols; it is not a universal substitute for medical care, particularly for children with complications requiring inpatient treatment. Although much production was historically concentrated in France, Nutriset developed a broader manufacturing and partnership network. Reference material identifies production or partner facilities in several African countries, including Niger, Burkina Faso, Ethiopia, Sudan, Madagascar, and Kenya, as well as Haiti and India. U.S. nonprofit organizations including Edesia Nutrition and Mana have also been identified as partners or manufacturers. Local and regional production can reduce transport distances and support supply in peanut-producing areas, although humanitarian supply chains remain exposed to forecasting errors, fragmented information flows, stock shortages, transport delays, and uneven payment and ordering systems. The brand has also been involved in a significant intellectual-property debate. Nutriset held patents covering aspects of nut-based nutritional pastes and defended those rights against organizations seeking to produce similar foods without a license. Médecins Sans Frontières criticized what it viewed as an overly restrictive approach to humanitarian licensing, while advocates of Nutriset's position argued that patents supported quality control, product development, and investment. In response to criticism, licensing arrangements were made available in parts of Africa, including provisions allowing qualifying nonprofit organizations to produce the paste without paying license fees. The cited U.S. patent expired in 2017, and corresponding patent protection in the United Kingdom and European Union expired in 2018. Plumpy'nut remains an important reference product within the RUTF category, while the broader humanitarian sector has continued to encourage multiple suppliers and locally adapted production.

Plumpy'nut emerged from an effort to make severe acute malnutrition treatment easier to deliver outside hospitals. In 1996, André Briend, a French pediatric nutritionist, and Michel Lescanne, a food-processing engineer, developed a peanut-based paste influenced in part by the familiar format of commercial spreads. Their objective was not to create an ordinary food product, but a therapeutic preparation capable of delivering concentrated energy and essential nutrients in a form that could be transported, stored, and consumed in difficult humanitarian conditions. The resulting product combined peanut paste, sugar, vegetable oil, skimmed milk powder, vitamins, and minerals. It was packaged in small, durable, tear-open sachets. The format addressed several practical problems associated with conventional treatment. Therapeutic milk generally requires water, preparation, equipment, and, in many circumstances, a clinical setting. Plumpy'nut could be eaten directly, did not require refrigeration, and had a shelf life reported at approximately two years. These characteristics made it suitable for community-based programs in which health workers identify and monitor children while families administer the food at home. The product became part of the expanding ready-to-use therapeutic food category. RUTFs are intended for severe acute malnutrition and are distinct from ordinary peanut butter, fortified blended foods, and routine child-feeding products. Their use helped humanitarian agencies treat more children without admitting every patient to a therapeutic feeding center. The United Nations recognized the growing evidence for community-based management, and UNICEF and the European Commission's humanitarian operations applied the approach during the 2007 Niger malnutrition emergency. Plumpy'nut consequently became strongly associated with famine relief, emergency nutrition, and child-survival interventions. Nutriset initially produced much of the product in France. Over time, the company and its partners supported a more distributed production model. Reference material identifies factories or partner facilities in Niger, Burkina Faso, Ethiopia, Sudan, Madagascar, Kenya, Haiti, and India, while U.S. nonprofit organizations such as Edesia Nutrition and Mana have also been associated with production. Local manufacture can improve responsiveness and reduce the logistical burden of shipping finished goods, especially in regions where peanuts and other inputs are available. At the same time, the product's global supply chain depends on demand forecasts, orders, payments, quality assurance, stock reporting, and transportation across multiple organizations. Fragmented or delayed information can reduce efficiency and contribute to shortages or late deliveries. The brand's history includes a protracted patent controversy. Nutriset held patents in several countries covering production methods or formulations for nut-based nutritional pastes, including U.S. patent 6,346,284 and European patent EP 1032280 as cited in reference material. The company defended those rights against non-licensees, including organizations that wanted to manufacture comparable therapeutic foods in the United States or export similar products into countries where protection remained in force. In 2010, two U.S. nonprofit organizations challenged the patent position but did not prevail. Critics argued that the patent created excessive supplier concentration and restricted access to a life-saving humanitarian product. Médecins Sans Frontières separately criticized the enforcement strategy and called for simpler licensing terms. Nutriset responded in part by permitting companies and nonprofit organizations in certain African countries to produce the paste without license fees. This approach did not eliminate the broader debate over intellectual property, but it enabled some regional production. A UNICEF-commissioned study also supported diversification of the RUTF supplier base as a way to strengthen global availability. The cited U.S. patent expired in 2017, followed by expiration of the relevant United Kingdom and European Union protection in 2018. Plumpy'nut continues to function as a reference brand for therapeutic food, while the wider RUTF field includes products from other manufacturers and locally produced alternatives.

• 2018

  United Kingdom and European Union patents expire

  [1]Plumpy'nuten.wikipedia.org

  The patent protection cited for the United Kingdom and European Union expires.

• 2017

  U.S. patent expires

  [1]Plumpy'nuten.wikipedia.org

  The cited U.S. patent covering the relevant nutritional-paste technology reaches the end of its term.

• 2010

  Patent dispute reaches U.S. courts

  [1]Plumpy'nuten.wikipedia.org

  Two U.S. nonprofit organizations unsuccessfully challenge Nutriset's patent rights in an effort to manufacture the product without royalties.

• 2007

  Community-based RUTF treatment is deployed in Niger

  [1]Plumpy'nuten.wikipedia.org

  UNICEF and the European Commission's humanitarian services use ready-to-use therapeutic food in the Niger malnutrition emergency.

• 2002

  U.S. patent is published

  [1]Plumpy'nuten.wikipedia.org

  U.S. patent 6,346,284, cited in relation to Nutriset's nut-based nutritional paste technology, is published.

• 1996

  Plumpy'nut is developed

  [1]Plumpy'nuten.wikipedia.org

  André Briend and Michel Lescanne create the peanut-based therapeutic paste that becomes Plumpy'nut.

A shelf-stable, portable, ready-to-use therapeutic food for community-based and emergency treatment of severe acute malnutrition.

• Ready-to-use therapeutic food · 1996

  Plumpy'nut

  A peanut-based therapeutic paste packaged in an individual sachet, commonly described as weighing about 92 grams. It contains peanut paste, sugar, vegetable oil, skimmed milk powder, vitamins, and minerals. The sachet can be opened and consumed without adding water, cooking, or refrigeration. It is intended for prescribed or program-managed treatment of severe acute malnutrition, especially where outpatient and community-based care is appropriate. It is not positioned as routine food or a general-purpose nutritional supplement.

• 2010

  Patent-access controversy

  Nutriset's enforcement of patents associated with Plumpy'nut drew criticism from Médecins Sans Frontières and other humanitarian actors. Critics argued that restrictive licensing and supplier concentration could limit the availability of therapeutic food. The controversy included a U.S. legal challenge by nonprofit organizations and a separate dispute involving a Norwegian company seeking to export a similar product to Kenya.

  Source

Read more

• 2010

  Defense of patent rightsOther

  Background

  Nonprofit organizations sought to manufacture Plumpy'nut or similar therapeutic pastes without paying royalties, while humanitarian groups questioned whether patent enforcement was appropriate for emergency nutrition.

  Action taken

  Nutriset defended its patent position in litigation and in disputes involving nonlicensed production and export.

  Aftermath

  The company faced sustained criticism but also made licensing concessions in some African countries, while calls for a diversified RUTF supplier base increased.

  • Médecins Sans Frontières — Médecins Sans Frontières publicly criticized the enforcement approach and called for practical humanitarian licensing terms.

  Source

• 2007

  Use of community-based therapeutic-food treatment in NigerStrategy

  Background

  A major malnutrition emergency created demand for treatment methods that could reach children beyond inpatient feeding centers.

  Action taken

  UNICEF and the European Commission's humanitarian services used ready-to-use therapeutic food within a community-oriented response.

  Aftermath

  The response illustrated the scalability of RUTF-based treatment in emergency settings and reinforced Plumpy'nut's humanitarian positioning.

  Source

• 1996

  Launch of a shelf-stable therapeutic pasteProduct launch

  Background

  Severe acute malnutrition was often treated through feeding centers using therapeutic milk, which required preparation and clinical infrastructure.

  Action taken

  Nutriset introduced a peanut-based, ready-to-use paste in single-use sachets that could be administered without water or refrigeration.

  Aftermath

  The format supported expansion of outpatient and community-based treatment and became a leading reference in the RUTF category.

  Source

1. 1Plumpy'nuten.wikipedia.org
2. 2Nutrisetnutriset.fr